OBINUTUZUMAB, RITUXIMAB clinical trials

Efficacy and safety of obinutuzumab versus rituximab in combination with chemotherapy for adult patients with newly diagnosed CD20-positive acute lymphoblastic leukemia

This study is looking at two different treatments, obinutuzumab and rituximab, along with standard chemotherapy for adults newly diagnosed with a type of blood cancer called acute lymphoblastic leukaemia. It aims to see which combination works best to put the cancer into remission.